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Purpose: To compare the effectiveness of radiofrequency ablation using a monopolar cluster and a bipolar
multipolar electrode for the ablation of (P2.5 cm) hepatocellular carcinoma.
Methods: 34 patients with a single HCC (mean size, 4.46 ± 2.3 cm; range, 2.5–7.4 cm) underwent percu-
taneous RFA with monopolar cluster (n = 18) or bipolar multipolar electrodes (n = 16). Technical success,
technical effectiveness, major complications, and tumor progression were compared.
Results: Technical success was achieved in 83, 3%, and 81.3% of patients in the monopolar cluster and
bipolar multipolar group respectively. Technical effectiveness was achieved in 87.5% and 94.4% of
patients treated by monopolar cluster electrodes and bipolar multipolar electrodes, respectively
(P = 0.591). No major complications were developed. Follow-up mean period was 21.4 months. The med-
ian local tumor progression rates were 17.7 and 22.7 months in the monopolar cluster and bipolar mul-
tipolar group respectively. On multivariate analysis, the use of a monopolar cluster electrode (P = 0.239)
was risk factor for complication.
Conclusion: There were no differences in terms of complete ablation, local tumor progression, distant
recurrence, and complication rates, but the overall survival regarding the distant recurrence and the life
expectancy is better in bipolar multipolar electrodes compared to the monopolar cluster electrodes.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
The success of the radiofrequency ablation (RFA) in the treat-
ment of heptocellular carcinoma (HCC), which is equal or less to
3 cm [1], encouraged many of the pioneers of this science, and
manufacturers, to try to ablate the larger tumors, and especially
it is known necessarily impossible to subject patients with these
diseases for surgery, or even for the treatment by chemoemboliza-
tion to dangerous exposure to liver failure [2].
Because the complete ablation of a tumor requires safety mar-
gins, these performances are clearly insufficient for the proper
treatment of a tumor target larger than 3 cm in a single application.
Therefore, to ensure entire coverage of the targeted zone with
monopolar devices, multiple overlapping RF ablations with succes-
sive positioning of the electrode are required [3]. Threatening thesuccess of the entire procedure, raises the need for a number of
procedures to control, raising the rates of incidence of distant
recurrence and raising the percentage of complications that you
may encounter patients [4].
The manufactures in turn, have tended to develop the elec-
trodes with the ability to ablate a large tumor size, by using the
development in the designs of those electrodes [5,6].
In our study, we tried the comparison between the two types of
these electrodes, representing a difference between them in the
mode of action, and designs at that time, which will help us to
reach a comprehensive vision in dealing with large HCC tumors
in general. Although both of the electrodes had been used in previ-
ous studies, the comparison between them did not occur.
Electrodes used in the study differ in their mode of action and
designs. The first is the monopolar cluster electrode [7], which
requires ground pad, and the second is the bipolar multipolar elec-
trode [8,9].
So, the role of this study is based on the measurement of the
efficiency of each of the electrode to ablate a medium sized HCC
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that researchers can take advantage of that study to target a larger
number of patients with HCC.2. Materials and methods
2.1. Study design
In accordance with a protocol approval by our institutional
review board, radiology reports, laboratory, and medical records
were retrospectively reviewed in all patients with HCCs, who ini-
tially managed by percutaneous RFA using monopolar cluster and
bipolar multipolar devices. In compliance with local policy, no
approval by an internal review board was required for this retro-
spective study. However, it was in accordance with common ethi-
cal guidelines and with the Declaration of Helsinki [10].2.2. Patient selection
Between January 2012 and September 2014, 34 patients under-
went percutaneous RF ablation for the treatment of HCC in our
institution, 18 with the monopolar cluster device and 16 with
the bipolar multipolar device. The location of the tumor was not
a contraindication unless it was close to the colon or main bile
ducts (<1 cm distance from tumor margin) on pretreatment imag-
ing including triphasic enhanced computed tomography (CT) and/
or magnetic resonance (MR) imaging and ultrasound (US) exami-
nations, all performed less than 1 month before treatment. All
patients had a prothrombin time of at least 40% and a platelet
count of at least 40,000/mL. We selected all patients in the
monopolar cluster electrode group (n = 18) and multipolar internal
cooled electrode group (n = 16) who met the following criteria: no
more than one tumor, each equal or larger than 2.5 cm in greatest
axial diameter; no detectable extrahepatic or intravascular spread-
ing; and histologically proven Child-Pugh class A/B cirrhosis.
According to the American Association for the Study of Liver Dis-
eases practice guidelines [10], the diagnosis of HCC for patients
with cirrhosis was based on noninvasive criteria: for tumors larger
than 2 cm that showed a ‘‘washout” on the venous phase in addi-
tion to a typical hypervascular pattern on the arterial phase, only
one dynamic imaging modality (CT or MR) was sufficient to nonin-
vasively make the diagnosis of HCC, and if the serum a-fetoprotein
(AFP) level was greater than 200 ng/mL in a tumor larger than
2 cm, noninvasive diagnosis of HCC was made regardless of
enhancement pattern.2.3. RF ablation
All RFA procedures performed percutaneously under ultrasound
guidance. We used multiple electrode system during all proce-
dures. Two types of electrodes were used with a 200-W radiofre-
quency generator: (1) Celon ProSurge Bipolar electrodes (Celon,
Teltow, Germany) with 3 cm active tip were deployed. These elec-
trodes are 1.8 mm in diameter and 15 cm or 20 cm in total needle
length used to treat 16 patients. The electrodes were used with
coolant pump to have internal cooling. No grounding pads were
needed with this device. Two or three electrodes were deployed
according to the tumor size and location, and (2) a single 15-cm,
17-gauge internal cooled electrode (Cool-tip; Radionics/Tyco,
Burlington, Massachusetts) with a 3-cm distal active tip and ther-
mistor. Sterile water at 4 C was diffused into the internal lumen of
the electrodes with a peristaltic pump to maintain a perfusion rate
of 10–25 mL/min. Two 100-cm2 grounding pads were applied to
the skin of the patient’s thighs used to treat 18 patients.All electrodes were placed via the trans-hepatic approach and
the ablation time depended on the perspective of the operator.
Patients were discharged from the hospital the day after overnight
clinical observation showed no complications.
2.4. Post treatment assessment and follow-up
According to our internal rules for the management of patients
with cirrhosis who undergo liver interventional procedures, the
patients remained hospitalized for at least 24 h after each
procedure.
In all cases, early response was assessed with tri-phasic CT car-
ried out 1 month after RF ablation. CT examinations with an initial
unenhanced entire liver pass were followed by an arterial and por-
tal phase of contrast material enhancement, interpreted reviewed
by the operator. A tumor was considered to be entirely ablated
when the ablation zone showed no inner or peripheral nodular
or irregular enhancement on arterial-phase CT. A thin (<5 mm) reg-
ular periablational ring of enhancement visible on the arterial
phase and persisting during the portal phase was considered a
benign inflammatory response to thermal injury.
After each RF ablation procedure, in the case of residual tumoral
tissue detectable on CT scan 1 month after the procedure, an addi-
tional RF ablation was attempted with the same RF devices if the
patient still met the inclusion criteria required for the first proce-
dure. Therefore, in practice, a complete treatment course could
require a maximum of two RF ablation procedures separated by
at least 1 month. If residual viable tumor persisted after the second
RF ablation procedure (or the first procedure if a second RF proce-
dure could not be attempted), the RF ablation treatment was con-
sidered incomplete.
After treatment, serum AFP determination, US, and triphasic
spiral CT were performed every 3 months. During follow-up, com-
plications, tumor progression, and death were recorded. For
tumors considered completely ablated on CT examination per-
formed 1 month after the last RF ablation procedure, local tumor
progression was defined by the appearance of a nodular or irregu-
lar ring of enhancement in contact with the ablation zone or any
thickening beyond 5 mm of the periablational ring detected at
1 month.
Distant intrahepatic tumor progression was defined as the
emergence of one or multiple tumor(s) not adjacent to the ablation
zone.
2.5. Efficacy and complications
The rate of complete tumor ablation, the number of RF applica-
tions, and the number of sessions per tumor treatment were
recorded for each group. The 1- and 2-year probabilities of local
and distant tumor progression were computed. Patients were
observed for any occurrence of adverse effects in line with the
guidelines of the Society of Interventional Radiology [12].
2.6. Statistical analysis
Baseline characteristics were expressed in terms of patients and
tumors. Comparisons between treatment with the monopolar clus-
ter and bipolar multipolar electrodes were performed with the v2
test and Fisher exact test for categorical variables and the t test for
continuous variables. The primary endpoint was defined as com-
plete necrosis assessed on CT. The secondary endpoints were com-
plication rate, local and distant tumor progression after 1 and
2 years, and death. The effect of the type of electrode on immediate
response and local tumor progression was computed per nodule
whereas distant tumor progression was computed per patient.
Probabilities of outcomes were estimated by the Kaplan–Meier
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tivariate analysis was performed with the Cox proportional-
hazards model. All statistical analyses were performed with STATA
software (version 9.0; STATA, College Station, Texas).3. Results
3.1. Patient characteristics
The characteristics of the patients and tumors in this study are
summarized, in Tables 1 and 2. At the time of RFA, all patients had
cirrhosis. Of the 34 patients, 13 patients were positive for hepatitis
B virus, 15 patients were positive for hepatitis C virus, and six
patients were mixed for both viruses At the time of RFA, all
patients had cirrhosis. The tumor mean size of 34 patients was,
4.46 ± 2.3 cm; range, 2.5–7.4 cm. The mean tumor size was
4.57 ± 0.33 cm (median size, 4.15 cm; range, 3–7.2 cm) in the
monopolar cluster group, and 4.35 ± 0.33 cm (median size, 4 cm;
range, 2.5–7.4 cm) in the bipolar multipolar group. There were
no practical differences between two groups in patient age, sex,
positivity for hepatitis B or C virus, increase in serum a-
fetoprotein, Child-Pugh score, median tumor size, or tumor loca-
tion (i.e. subcapsular or non-subcapsular).Table 1
Baseline characteristics of 34 patients treated with RF ablation.
Characteristic Total BM
Patients 34 16
Tumors 34 13
Patient characteristics
Sex (M/F) 24/10 9/7
Mean age (y) ± SD 67.34 ± 2 70
Etiology of cirrhosis
 HBV 13 3
 HCV 15 9
 HBCV 6 4
Child-Pugh class
 A 28 14
 B 6 2
Esophageal varices
 Yes 16 8
 No 18 8
AFP
 0 < AFP 6 20 20 11
 20 < AFP 6 200 mg 7 3
 200 mg < AFP 6 2
Note.
HCV = hepatitis C virus.
HBV = hepatitis B virus.
HBCV = hepatitis B&C virus.
BMG = bipolar multipolar group.
MCG = monopolar cluster group.
AFP = a-fetoprotein.
Table 2
Baseline characteristics of 34 HCCs treated with RF ablation.
Characteristic Total
Tumor characteristics
Mean size ± SD (mm) 44,6 ± 2.3
Tumor location
 Right lobe 23
 Left lobe 11
Subcapsular tumor 7
Note.
BMG = bipolar multipolar group.
MCG = monopolar cluster group.3.2. Technical success and effectiveness
No technical failures occurred, see Figs. 1 and 2. The rate of
complete tumor ablation per tumor treated was 94.4% in monopo-
lar cluster group and 87.5% in bipolar multipolar group. More than
one RF application per procedure was performed in one of 18 cases
in the cluster group (5.6%; range, 1–2 applications), and 1 of 16
cases in the bipolar multipolar group (6.25%; range, 1–2 applica-
tions, P = 0.013). More than one session was undertaken per treat-
ment in one of 18 tumors (5.6%) in the monopolar cluster group,
and one of 16 tumors (6.25%) in the bipolar multipolar group, see
Fig. 3 (P = 0.013; Table 3). This means that the bipolar multipolar
electrode requires a significant total number of applications and
sessions to achieve a complete necrosis (see Figs. 4 and 5).3.3. Tumor progression
The follow-up mean period was, 21.375 ± 1.07 months; range,
19–23 months. During follow-up, local tumor progression occurred
in 3 (16.7%) of 18 patients in the monopolar cluster group and in 3
(18.75%) of 16 patients in the bipolar multipolar group. The aver-
age local tumor progression rates were 17.7 ± 1.6 months in the
cluster type group and 22.7 ± 0.9 months in the bipolar multipolarG MCG P value
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Fig. 1. A 62 years old man with 6 cm HCC successfully treated with bipolar multipolar radiofrequency (a) CT at arterial phase, (b) US transverse views at the beginning of RF
energy deposition, (c) US transverse (on the left) and longitudinal (on the right) views at fee end of RF energy deposition, (d) CT at arterial phase performed 1 month after RF
ablation procedure.
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multipolar group, compared to cluster group. However the log
Rank (Mantel-Cox) was not decisive, P = 0.036.3.4. Complications
The mean hospital stay durations in the monopolar cluster and
bipolar multipolar groups were 1.06 days ± 0.33 (range, 1–3) and
1.06 days ± 0.25 (range, 1–2), respectively.
In the cluster group, one minor periprocedural complication
occurred: a 1-day after ablation, one patient developed low grade
fever that resolved after 5 days using paracetamol. In the bipolar
multipolar group, two minor periprocedural complications
occurred: 2 days after RF ablation, two patients developed ascites
that resolved within 7 days after diuretic treatment.3.5. Overall and disease-free survival rates
There were 8 (23.6%) deaths among the 34 patients during the
follow-up period. The cause of death due to liver failure occurred
in 2 patients treated with cluster electrode Distant tumor progres-
sion was the cause of death in 6 patients. Three patients were trea-
ted with monopolar cluster electrode and three patients with
bipolar multipolar electrode.
Table 4 shows during follow-up period, death in the treated
patients occurred in five (27.8%) of 18 patients in the cluster group,
and in 3 (18.75%) of 16 patients in the bipolar multipolar group.
The average death rates were 16.95 ± 1.9 months in the cluster
type group and 23.7 ± 1.1 months in the bipolar multipolar group.
The average time of survival (average time without death) was bet-
ter in case of bipolar multipolar group, compared to cluster group,
log Rank (Mantel-Cox) was, p = 0.004.
Table 5 explains the Kaplan–Meier analysis for factors associ-
ated with overall Survival.4. Discussion
Despite the fact that a multiple-electrode RF ablation is a safe
and effective procedure for ablation of medium sized HCC, caution
dictates that RF ablation results be considered not as a whole but
according to the technique used [13].
In this study, we compared two different systems of RF ablation,
both of which used multiple electrodes. The first system with
monopolar cluster electrode does not require precise parallel elec-
trode placement because each electrode is electrically independent,
and requires the use of ground pads. The later systemwas the bipo-
lar multipolar electrode in which current flow is confined to tissue
between electrodes and does not require the use of ground pads. In
our study, even though the results were similar in terms of com-
plete ablation, local tumor progression, distant recurrence, and
complication rates, but the overall survival regarding the distant
recurrence and the life expectance is better in case of bipolar mul-
tiple electrodes compared to the monopolar cluster electrodes.
As a whole, distant tumor recurrence may be explained by
intrahepatic metastasis or the occurrence of new emerging tumors
from the underlying chronic liver disease [14]. In patients with cir-
rhosis, after curative treatment of HCC, the incidence of distant
tumor recurrence is estimated at 10–15% per year [15] and, at least
in the case of successfully ablated small tumors, distant tumor
recurrence seemed mainly to result from the occurrence of new
independent tumors [15]. The distant tumor recurrence rate
observed in our bipolar multiple electrode group is within the
range reported in the literature after surgical resection [14,15] or
percutaneous ablation [16]. On the other side, with the monopolar
cluster electrodes, we observed a greater rate of distant tumor
recurrence.
Clarification optimized for such an outcome, can be explained
by Goldberg et al. [14] during the development of the cluster
electrode; when multiple electrodes from the same power source
are placed in close proximity, a weak current flows between the
electrodes because they are at the same voltage. This factor
Fig. 2. (a) Arterial dominant phase axial CT scan obtained before ablation using monopolar cluster electrode shows hypervascular lesion (arrow) in posted or segment, right
lobe. (b) Portal venous phase, the lesion appears hypo attenuating. (c) Enhanced CT scan obtained 1 month after ablation shows non-enhancing RFA area with peripheral
enhancement (arrow) on arterial dominant phase. (d) Portal dominant phase axial CT scan does not show peripheral enhancement. (e) CT scan obtained after second session
of ablation 1 month after c shows successful ablation with extensive ablated margin up to the crura of right diaphragm. Notice right pleural effusion, a common finding after
ablation of lesion adjacent to diaphragm. (f) Portal dominant phase axial CT scan shows same findings as in e.
M.I.M. Ahmad / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1443–1449 1447fundamentally limits the distance at which the electrodes can be
separated owing to cool spots in the center of the ablation.
Commercially available cluster electrodes are limited by the
weak current flow between electrode prongs. Attempting to
increase the ablation zone size by setting the prongs further apart
would cause increased irregularity in the shape of the induced
coagulation, which is already a problem with these electrodes
[17]. In addition, with cluster electrode system there is inability
to distinguish viable tumor from necrotic tissue on immediate post
ablation imaging. This resulted in premature termination of proce-
dures before achieving adequate necrosis of the entire tumor and a
surrounding ablative margin [18].
On the other side, with the bipolarmultipolar electrode, the exis-
tence of the two electrodes on the same system prevents the occur-
rence of this gap, as each electrode can be a unit consistent with
anotherelectrodeon the sameor theparallel system, so sixharmonic
electrodes in the presence of two parallel systems can be noted [14].
Another shortcoming of monopolar cluster electrodes is the
presence of the heat-sink effect if the index tumor is close to a
large vessel (>3 mm) [18,14].In the terms of complication, no major complication occurred in
this series, and the minor complication rates appear to be similar
between cluster and bipolar multiple-electrode systems.
When studying these types of multiple electrodes, we must be
keep in mind the privacy of these electrodes in dealing with large
tumors, which in turn means the large number of electrode place-
ment and complications resulting either from the size of the tumor
and its effect on the liver or from neighboring critical structures or
the number of the electrode placement and the chance of distant
tumor recurrence.
Placement of bipolar multiple electrodes in this study was not
difficult compared with placing monopolar cluster electrode,
which does not require precise parallel electrode placement. Place-
ment of the first electrode generally took the longest because of the
need to find a suitable window and approach, but subsequent
placements were generally faster because the first electrode could
be used as a guide needle.
To our knowledge, this is the first study to compare the safety
and efficacy of RFA using monopolar cluster and bipolar multiple
electrodes in patients with medium-sized HCCs.
Fig. 3. A 68 years old man with 6.5 cm HCC incompletely ablated after 1 multipolar radiofrequency procedure:(a) US transverse (on left) and longitudinal (on right) views
before treatment, (b) US transverse (on left) and longitudinal (on right) views just after the end of RF procedure, (c) CT at arterial phase performed 1 month after RF ablation
procedure shows tumor almost completely ablated but (d) few cm above c, CT at arterial phase shows persistent of viable tumor (arrow) requiring complementary additional
RF procedure.
Table 3
Influence of type of electrode used on therapeutic response and course of treatment in 34 tumors treated with RF ablation.
Total BMG group MCG group P value
Complete ablation 31 14 17 0,455
Incomplete ablation 3 2 1
No. of RF applications 0.013
1 32 15 17
P2 2 1 1
No. of sessions 0.013
1 32 15 17
2 2 1 1
Note.
Values are presented as numbers of tumors where appropriate.
BMG = bipolar multipolar group.
MCG = monopolar cluster group.
Fig. 4. Graph shows the average time of survival (average time without death) is
better in the case of the bipolar multipolar electrode (23, 7 months), compared to
fee cluster electrode (16, 9) months. Significant difference was noted between two
groups. Log Rank (Mantel-Cox), p = 0,004.
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ization, which may have introduced a bias. However, patients were
selected only on the basis of objective criteria, both groups had
similar baseline characteristics with regard to underlying cirrhosis
and tumor characteristics, and both were treated over a short per-
iod of time by the same operator in the same center. The relatively
small number of patients included in this study could also be con-
sidered a limitation. It is relevant that, in a secondary or tertiary
center such as ours, many patients referred for RF ablation have
larger tumors or are referred for local recurrences, which would
violate the inclusion criteria because of the more advanced stage
of their disease.
In conclusion, percutaneous RFA using bipolar multipolar elec-
trodes is better in overall survival regarding the distant recurrence
and the life expectance compared to the monopolar cluster
electrodes.
Fig. 5. Graph shows the average time of survival (average time without recurrence) is better in case of bipolar multipolar electrode (22.7 months), compared to cluster
electrode (17.7 months). No significant difference was noted between the two groups (P = 0.036, log-rank test).
Table 4
Influence of type of electrode used on tumor progression (recurrence) and life at 2 years.
Total BMG group MCG group P value
No recurrence 28 13 15 0.611
Recurrence 6 3 3
Live 26 13 13 0.693
Death 8 3 5
Note.
Values are presented as numbers of tumors where appropriate.
BMG = bipolar multipolar group.
MCG = monopolar cluster group.
Table 5
Kaplan–Meier analysis for factors associated with overall survival.
Variable No. of living cases P value age (y)
Etiology of cirrhosis 0.823
 HBV 11
 HCV 13
 MIXED 4
Complete ablation 0.006
 Yes 26
 NO 0
Recurrence 0.204
 BMG 13
 MCG 15
Death 0.004
 BMG 13
 MCG 13
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